Yoo Roh-Eul, Kim Ji-Hoon, Paeng Jin Chul, Park Young Joo
Department of Radiology, Seoul National University College of Medicine, Seoul, Korea Department of Nuclear Medicine Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Medicine (Baltimore). 2018 Mar;97(9):e0003. doi: 10.1097/MD.0000000000010003.
Long-term recurrence rate of differentiated thyroid carcinoma has been reported to be as high as 30%. Repeat surgery may be challenging due to normal tissue plane distortion secondary to postoperative fibrosis, especially for small-sized recurrences. Recently, radiofrequency ablation (RFA) has been suggested to be a safe and effective alternative for high-risk patients or those who refuse surgery. Nonetheless, the efficacy of RFA remains questionable for densely calcified lymph nodes, which would have an increased likelihood of leaving residues after RFA.
We present a case of a successful combined treatment of a metastatic lymph node with dense macrocalcification with the use of a single RFA session and radioactive iodine (RAI) ablation in a patient with a previous history of total thyroidectomy and neck node dissection for papillary thyroid carcinoma.
A 71-year-old man with papillary thyroid carcinoma underwent total thyroidectomy and neck node dissection followed by RAI ablation. The stimulated serum thyroglobulin level was 4.74 ng/mL at the time of RAI ablation, and the follow-up ultrasonography 3 months later revealed a 15-mm lymph node with dense macrocalcification at the right cervical level III.
After confirming metastasis on cytology, the lesion was treated with ultrasound-guided RFA.
The single RFA session combined with RAI ablation led to biochemical remission at 5 months after RFA, and complete resolution of structural recurrence including macrocalcification was observed 7 months after the second RAI (1 year after RFA). The patient remained free of recurrence at the 5-year follow-up.
RFA may offer a safe and effective alternative to 'berry picking' surgery in cases of surgical ineligibility or patient refusal of surgery even when the target lesions contain dense macrocalcification.
据报道,分化型甲状腺癌的长期复发率高达30%。由于术后纤维化导致正常组织平面变形,再次手术可能具有挑战性,尤其是对于小尺寸复发灶。最近,射频消融(RFA)已被认为是高危患者或拒绝手术患者的一种安全有效的替代方法。尽管如此,对于密集钙化的淋巴结,RFA的疗效仍存在疑问,因为RFA后残留的可能性会增加。
我们报告一例成功联合治疗转移性淋巴结伴密集粗大钙化的病例,该患者既往有甲状腺癌全切及颈部淋巴结清扫病史,采用单次RFA治疗及放射性碘(RAI)消融。
一名71岁男性乳头状甲状腺癌患者接受了甲状腺全切及颈部淋巴结清扫,随后进行RAI消融。RAI消融时刺激血清甲状腺球蛋白水平为4.74 ng/mL,3个月后的随访超声显示右侧颈Ⅲ区有一个15 mm的淋巴结伴密集粗大钙化。
在细胞学检查确认转移后,对病变进行超声引导下的RFA治疗。
单次RFA治疗联合RAI消融在RFA后5个月实现了生化缓解,第二次RAI(RFA后1年)后7个月观察到包括粗大钙化在内的结构复发完全消退。患者在5年随访中无复发。
即使目标病灶包含密集粗大钙化,在手术不可行或患者拒绝手术的情况下,RFA可能为“摘莓样”手术提供一种安全有效的替代方法。